Hepatitis B or non-A, non-B virus infection in multitransfused thalassaemic patients.
- 1 December 1984
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 59 (12), 1127-1130
- https://doi.org/10.1136/adc.59.12.1127
Abstract
A 4 yr study of 128 thalassemic patients who had undergone several transfusions was performed to determine the incidence of hepatitis B virus markers and the activities of transaminases in their sera each month. The possibility of these patients contracting hepatitis B virus infection is still high, although on only one occasion was a transient antigenemia found, indicating low viral replication. The probability of contact with hepatitis B virus increases with the number of transfusions and, therefore, with age. About 25% of these patients were positive for hepatitis B markers and 80% for other hepatitis markers including the case of cytomegalovirus hepatitis.This publication has 18 references indexed in Scilit:
- Cirrhosis associated with multiple transfusions in thalassaemia.Archives of Disease in Childhood, 1984
- Hepatitis‐Associated Markers in the American Red Cross Blood Donor PopulationVox Sanguinis, 1983
- POST-TRANSFUSION HEPATITIS IN ITALYThe Lancet, 1982
- Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.Gut, 1982
- POST-TRANSFUSION HEPATITIS IN AUSTRALIAThe Lancet, 1982
- Antibody to Hepatitis B Core Antigen in Blood Donors with a History of HepatitisTransfusion, 1981
- Sequential study of liver biopsy in thalassaemia.Archives of Disease in Childhood, 1980
- Prevalence of hepatitis A and B infections in multiply transfused thalassaemic patients.BMJ, 1978
- Role of chronic hepatitis in development of thalassaemic liver disease.Archives of Disease in Childhood, 1976
- The Incidence of Hepatitis‐Associated Antigen and Antibody in Patients with Thalassaemia in GreeceVox Sanguinis, 1970